Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $132.45. The company's market cap stands at 334.75B, with a P/E ratio of 35.92 and a dividend yield of 2.63%.
On 2026-07-27, Merck(MRK) stock traded between a low of $130.53 and a high of $132.53. Shares are currently priced at $132.45, which is +1.5% above the low and -0.1% below the high.
Merck(MRK) shares are trading with a volume of 1.48M, against a daily average of 8.83M.
During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $132.53 at its peak.
During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $132.53 at its peak.
MRK News
In July 2026, Merck announced an early, multi-pronged access plan for its investigational once-monthly HIV PrEP pill alimatravir (MK-8527), including royalty-fr...
Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.65% in the past week. It has experienced a 5-day net inflow of $682.61 million. This is due, in part, to...
Merck (MRK) announced early components of a multi-faceted strategy to provide rapid, broad and sustainable access in low- and middle-income countries to alimatr...
Analyst ratings
66%
of 29 ratingsMore MRK News
Gilead (GILD) Sciences announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has adopted a posit...
...
Merck (NYSE:MRK) is seeing new clinical progress for its KEYTRUDA franchise in Europe and in hard to treat cancers. Agilent received EU approval to use its PD-...
Why Retirees Are Choosing This $100.8 Billion ETF Over Individual Dividend Stocks By David Beren Published Jul 23, 11:27AM EDT Quick Read SCHD's 3.2% yield co...
Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Merck & Company, retaining the price target of $141.00. Unlock powerful investi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.